BRISTOL-MYERS SQUIBB’s PROHANCE NON-IONIC MRI CONTRAST AGENT APPROVED FOR CNS DISORDERS; SHIPPING BEGINS "IMMEDIATELY," UNIQUE DOSING OPTIONS STRESSED BY BMS